by Theo Smart and Lance Sherriff Why revisit this session? The Lancet HIV Commission on aging and HIV is a substantial report with its own executive summary, and we encourage readers to review it. Published several months after AIDS 2026, this article instead looks back at what commissioners emphasized in Rio de Janeiro against broader
Editor’s note: A slightly different version of this overview was first published by ICAP at Columbia University. You can read that version here: At AIDS 2026, Advanced HIV Disease Goes Under the Microscope. We’re sharing the original Treatment Science Writers version as the first entry in a small series on Advanced HIV Disease at AIDS
AIDS 2026 Rio: Advanced HIV Disease Persists Despite Gains in HIV Treatment Read More »
We have full time work, but at times we have access to information and news that we think is important to share and haven’t the time to market our work to other news sites. Again, because we are trying to maintain our full-time jobs… Nevertheless, here’s some recent material we’ve thought it might be useful
Reactivating this site for a time Read More »
[Lance Sherriff assisted in the transcription and compilation of this article.] Fatty liver disease (hepatic steatosis) was found to be very common among people living with HIV in a cross-sectional study involving 160 people on antiretroviral treatment, according to data presented at the 9th International HIV and Aging Workshop last week in New York
[Lance Sherriff assisted in the transcription and compilation of this article.] Mitochondria (the small organelles in cells that are critical for energy production) within the muscle fibers of antiretroviral-treated people living with HIV may be significantly damaged, according to a study presented last week in New York at the HIV and Aging Workshop by researchers
Even newer NRTIs (anti-HIV drugs) found to cause mitochondrial damage in muscle Read More »
Many of the aging people living with HIV suffering the most may not be able to defend themselves. Key points: An ACT UP working group is starting to compile a list of HIV care facilities with experience treating long-term survivors and people living with HIV over the age of 50 who are experiencing aging-related
Last week, two members of ACT UP NY came to the general meeting to tell us about a crisis that has befallen, by their estimation, a few dozen older HIV+ clients who were receiving care from an HIV-specialist named Olivieri based in Manhattan who was arrested a few months back. Dr. Olivieri’s practice specialized in
Aging with HIV Crisis in New York City Read More »
Frailty, the condition of depleted energy and physiological decline that is often seen in the elderly and that makes them less capable of recovering from illness, accidents and the stresses of life, has been reported to be significantly more common in people living with HIV — even in middle-aged people on antiretroviral treatment (ART)
The high risk of frailty in middle-aged people living with HIV Read More »
Last week, I retweeted a press release from the NIH about a presentation that Tony Fauci was going to make at the AIDS Conference, which featured the lead quote “Durable control of HIV infection in the absence of antiretroviral therapy is a feasible concept that deserves vigorous pursuit.” This was referring to the ‘cure’
TB2016 was a two-day conference dedicated exclusively to TB that immediately preceded the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa. It convened TB implementers, TB scientists, infectious disease clinicians and scientists, health policy makers, and advocacy — but was held in conjunction with AIDS2016 in the hope that it would attract many